Relationships between the structure of spiro[[2]benzopyran-1,1′-cyclohexan]-4′-amines and their σ1 receptor affinity and selectivity

Martin, 1976, The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197, 517 Hanner, 1996, Purification, molecular cloning, and expression of the mammalian sigma1-binding site, Proc. Natl. Acad. Sci. U.S.A., 93, 8072, 10.1073/pnas.93.15.8072 Kekuda, 1996, Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1), Biochem. Biophys. Res. Com., 229, 553, 10.1006/bbrc.1996.1842 Seth, 1997, Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor, Biochem. Biophys. Res. Commun., 241, 535, 10.1006/bbrc.1997.7840 Seth, 1998, Cloning and functional characterization of a σ receptor from rat brain, J. Neurochem., 70, 922, 10.1046/j.1471-4159.1998.70030922.x Prasad, 1998, Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 σ receptor gene, J. Neurochem., 70, 443, 10.1046/j.1471-4159.1998.70020443.x Schmidt, 2016, Crystal structure of the human σ1 receptor, Nature, 532, 527, 10.1038/nature17391 Schmidt, 2018, Structural basis for σ1 receptor ligand recognition, Nature Struct. Mol. Biol., 25, 981, 10.1038/s41594-018-0137-2 Hayashi, 2007, Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival, Cell, 131, 596, 10.1016/j.cell.2007.08.036 Hong, 2017, The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats, J. Biol. Chem., 292, 11250, 10.1074/jbc.M116.774075 Bermack, 2001, modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands, Br. J. Pharmacol., 134, 691, 10.1038/sj.bjp.0704294 Martina, 2007, The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus, J. Physiol., 578, 143, 10.1113/jphysiol.2006.116178 Lupardus, 2000, Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-Protein nor ATP, J. Physiol., 526, 527, 10.1111/j.1469-7793.2000.00527.x Hayashi, 2000, Ca2+ signaling via sigma1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration, J. Pharmacol. Exp. Ther., 293, 788 Hellewell, 1994, Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling, Eur. J. Pharmacol., 268, 9, 10.1016/0922-4106(94)90115-5 Johannessen, 2009, Voltage-gated sodium channel modulation by σ-receptors in cardiac myocytes and heterologous systems, Am. J. Physiol. Cell Physiol., 296, C1049, 10.1152/ajpcell.00431.2008 Matsumoto, 2011, N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice, Eur. J. Pharmacol., 411, 261, 10.1016/S0014-2999(00)00917-1 Smith, 2016 Maurice, 2009, The pharmacology of sigma-1 receptors, Pharmacol. Ther., 124, 195, 10.1016/j.pharmthera.2009.07.001 Cobos, 2008, Pharmacology and therapeutic potential of sigma(1) receptor ligands, Curr. Neuropharmacol., 6, 344, 10.2174/157015908787386113 Sánchez-Fernández, 2014, Modulation of peripheral μ-opioid analgesia by σ1 receptors, J. Pharmacol. Exp. Ther., 348, 32, 10.1124/jpet.113.208272 Chien, 1995, Sigma antagonists potentiate opioid analgesia in rats, Neurosci. Lett., 190, 137, 10.1016/0304-3940(95)11504-P de la Puente, 2009, Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury, PAIN, 145, 294, 10.1016/j.pain.2009.05.013 Nieto, 2012, Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice, J. Pain, 13, 1107, 10.1016/j.jpain.2012.08.006 Cendán, 2005, Formalin-induced pain is reduced in sigma(1) receptor knockout mice, Eur. J. Pharmacol., 511, 73, 10.1016/j.ejphar.2005.01.036 Entrena, 2009, Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice, Pain, 143, 252, 10.1016/j.pain.2009.03.011 Sabino, 2009, Sigma-1 receptor knockout mice display a depressive-like phenotype, Behav. Brain Res., 198, 472, 10.1016/j.bbr.2008.11.036 Díaz, 2012, Synthesis and biological evaluation of the 1-arylpyrazole class of σ 1 receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-Yl)-1 H -Pyrazol-3-Yloxy]Ethyl}morpholine (S1RA, E-52862), J. Med. Chem., 55, 8211, 10.1021/jm3007323 Wünsch, 2012, The σ1 receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain, J. Med. Chem., 55, 8209, 10.1021/jm3011993 Bruna, 2018, Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: A randomized, double-blind, Placebo-Controlled Phase IIa Clinical Trial, Neurotherapeutics, 15, 178, 10.1007/s13311-017-0572-5 van Waarde, 2015, Potential applications for sigma receptor ligands in cancer diagnosis and therapy, Biochim. Biophys. Acta, 1848, 2703, 10.1016/j.bbamem.2014.08.022 Kim, 2017, sigma1 pharmacology in the context of cancer, Handb. Exp. Pharmacol., 244, 237, 10.1007/164_2017_38 Collina, 2017, Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996–2016), Exp. Op. Ther. Pat., 27, 565, 10.1080/13543776.2017.1276569 Quirion, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci., 13, 85, 10.1016/0165-6147(92)90030-A Weber, 2016, Rigidity versus flexibility: is this an issue in σ1 receptor ligand affinity and activity?, J. Med. Chem., 59, 5505, 10.1021/acs.jmedchem.6b00585 Große Maestrup, 2009, Evaluation of spirocyclic 3-(3-fluoropropyl)-2-benzofurans as σ1 receptor ligands for neuroimaging with positron emission tomography, J. Med. Chem., 52, 6062, 10.1021/jm900909e Maier, 2002, Novel spiropiperidines as highly potent and subtype selective σ receptor ligands. Part 1, J. Med. Chem., 45, 438, 10.1021/jm010992z Maier, 2002, Novel σ receptor ligands. Part 2. SAR of spiro[[2]benzopyran-1,4’-piperidines] and spiro[[2]benzofuran-1,4’-piperidines] with carbon substituents in position 3, J. Med. Chem., 45, 4923, 10.1021/jm020889p Große Maestrup, 2011, Synthesis, pharmacological activity and structure affinity relationships of spirocyclic σ1 receptor ligands with a (2-fluoroethyl) residue in 3-position, Bioorg. Med. Chem., 19, 393, 10.1016/j.bmc.2010.11.013 Kranz, 2016, Evaluation of the enantiomer specific biokinetics and radiation doses of [18F]-fluspidine – a new tracer in clinical translation for imaging of σ1 receptors, Molecules, 21, 1164, 10.3390/molecules21091164 Wiese, 2016, Comparison of in silico, electrochemical, in vitro and in vivo metabolism of a homologous series of (radio)fluorinated σ1 receptor ligands designed for positron emission tomography, ChemMedChem, 11, 2445, 10.1002/cmdc.201600366 Bunse, 2019, Short and atom-economic enantioselective synthesis of the σ1-receptor ligands (S)- and (R)-fluspidine – important tools for positron emission tomography studies, J. Org. Chem., 84, 13744, 10.1021/acs.joc.9b01882 Brune, 2014, The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding, Biochemistry, 53, 2993, 10.1021/bi401575g Laurini, 2011, Homology model and docking-based virtual screening for ligands of the σ1 receptor, ACS Med. Chem. Lett., 2, 834, 10.1021/ml2001505 Rack, 2011, Design, synthesis and pharmacological evaluation of spirocyclic σ1 receptor ligands with excocyclic amino moiety (increased distance 1), Bioorg. Med. Chem., 19, 3141, 10.1016/j.bmc.2011.04.002 Kronenberg, 2019, Synthesis and structure-affinity relationships of spirocyclic benzopyrans with exocyclic amino moiety, J. Med. Chem., 62, 4204, 10.1021/acs.jmedchem.9b00449 Abdel-Magid, 2006, A Review on the use of sodium triacetoxyborohydride in the reductive amination of ketones and aldehydes, Org. Process Res. Dev., 10, 971, 10.1021/op0601013 Hasebein, 2014, Synthesis and pharmacological evaluation of like- and unlike-configured tetrahydro-2-benzazepines with the α-substituted benzyl moiety in the 5-position, Org. Biomol. Chem., 12, 5407, 10.1039/C4OB00510D Meyer, 2013, Improvement of σ1 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones, Bioorg. Med. Chem., 21, 1844, 10.1016/j.bmc.2013.01.038 Miyata, 2014, Synthesis and σ receptor affinity of regioisomeric spirocyclic furopyridines, Eur. J. Med. Chem., 83, 709, 10.1016/j.ejmech.2014.06.073 Bourgeois, 2014, Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists, J. Med. Chem., 57, 6845, 10.1021/jm500940q Wenker, 2016, Synthesis and pharmacological evaluation of conformationally restricted κ-opioid receptor agonists, MedChemComm, 7, 2368, 10.1039/C6MD00441E Wittig, 2017, Stereoselective synthesis of conformationally restricted KOR agonists based on the 2,5-diazabicyclo[2.2.2]octane scaffold, Org. Biomol. Chem., 15, 6520, 10.1039/C7OB01530E Bergkemper, 2018, Synthesis, receptor affinity and antiallodynic activity of spirocyclic sigma receptor ligands with exocyclic amino moiety, J. Med. Chem., 61, 9666, 10.1021/acs.jmedchem.8b01183 Stresser, 2004, High-throughput screening of human cytochrome P450 inhibitors using eluorometric substrates. Methodology for 25 enzyme/substrate pairs, 215